Clinical trial
A Phase II, Open-Label, Multicenter Study of Orally Administered CA-4948 for the Treatment of Anemia in Patients With Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS)
NCT05178342 is registered in ClinicalTrials.gov with University of Leipzig as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II, Open-Label, Multicenter Study of Orally Administered CA-4948 for the Treatment of Anemia in Patients With Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS)
- Lead sponsor
- University of Leipzig
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- January 1, 2022
- Completion date
- July 31, 2024
- Enrollment
- 38 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.